A €5bn (£4.3bn) EU fund which invests in some of the continent's most promising scale-up technology companies is leading a $100m (£73.9m) funding round for Tandem Health, an AI medical assistant which has built a presence at the epicentre of Britain's private healthcare industry.
Sky News has learnt that Swedish-based Tandem Health will announce on Monday that it has finalised a Series B fundraising led by the Scaleup Europe Fund, which is managed by the Stockholm-based private equity behemoth EQT.
Tandem Health was launched with the aim of reducing the administrative burden associated with clinical healthcare by using AI to generate notes while medical experts speak to patients.
In the UK, the company has a partnership with Accurx which has given hundreds of thousands of NHS practitioners access to Tandem Health's technology.
Tandem Health cites evidence showing that clinicians using its products report a 29% reduction in the amount of time they spend on administrative tasks.
Its AI medical assistant prepares patient summaries prior to appointments, provides clinical decision support during consultations and automatically handles the documentation and coding which follows.
Tandem Health says it is used by 10,000 care organisations across 14 European countries.
Source: Sky News, 13 September 2026
Recommended Comments
Create an account or sign in to comment